EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
47 hedge funds and large institutions have $200M invested in Evelo Biosciences, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+5
Holders Change %
+11.9%
% of All Funds
0.97%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
23
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
+$22.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.52M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$6.37M |
| 4 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$6.37M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$6.13M |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$668K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$319K |
| 3 |
Bank of New York Mellon
New York
|
-$46.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$20.6K |
